Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection

Infection and Immunity

Volumn 64, Issue 8, 1996, Pages 3231-3235

  Dalrymple, Stacie A ^a,b   Slattery, Robyn ^a,c   Aud, Dee M ^a   Krishna, Mala ^a   Lucian, Linda A ^a   Murray, Richard ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Pharmagenesis   (United States)

^c Biology and Environment   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 6; RECOMBINANT INTERLEUKIN 6;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENTEROBACTER INFECTION; INFECTION PREVENTION; INFECTION RESISTANCE; INFECTION SENSITIVITY; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030036870     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.8.3231-3235.1996     Document Type: Article

References (25)

1. Barton, B. E., and J. V. Jackson. 1993. Protective role of interleukin 6 in the lipopolysaccharide-galactosamine septic shock model. Infect. Immun. 61:1496-1499.
2. Bellido, T., R. L. Jilka, B. F. Boyce, G. Girasole, H. Broxmeyer, S. A. Dalrymple, R. Murray, and S. C. Manolagas. 1995. Regulation of interleukin-6, osteoclastogenesis, and hone mass by androgens. The role of the androgen receptor. J. Clin. Invest. 95:2886-2895.
3. Biffl, W. L., E. E. Moore, F. A. Moore, and C. C. Barnett. 1995. Interleukin-6 suppression of neutrophil apoptosis is neutrophil concentration dependent. J. Leukocyte Biol. 58:582-584.
4. Borish, L., R. Rosenbaum, L. Albury, and S. Clark. 1989. Activation of neutrophils by recombinant interleukin 6. Cell Immunol. 121:280-289.
5. Conlan, J. W., and R. J. North. 1994. Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody. J. Exp. Med. 179:259-268.
6. Czuprynski, C. J., J. F. Brown, N. Maroushek, R. D. Wagner, and H. Steinberg. 1994. Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection. J. Immunol. 152:1836-1846.
7. Dalrymple, S. A., L. A. Lucian, R. Slattery, T. McNeil, D. M. Aud, S. Fuchino, F. Lee, and R. Murray. 1995. Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infect. Immun. 63:2262-2268.
8. Dinarello, C. A. 1989. The endogenous pyrogens in host-defense interactions. Hosp. Pract. 24:111-128.
9. Fattori, E., M. Cappelletti, P. Costa, C. Sellitto, L. Cantoni, M. Carelli, R. Faggioni, G. Fantuzzi, P. Ghezzi, and V. Poli. 1994. Defective inflammatory response in interleukin 6-deficient mice. J. Exp. Med. 180:1243-50.
10. Gulati, S., C. Bennett, J. Phillips, and C. Van-Poznak. 1993. GM-CSF as an adjunct to autologous bone marrow transplantation. Stem Cells 11:20-25.
11. Hack, C. E., E. R. Degroot, R. J. F. Felt-Bersma, J. H. Nuijens, R. J. M. S. Van Schijndel, A. J. M. Eerenberg-Belmer, L. G. Thijs, and L. A. Aarden. 1989. Increased plasma levels of interleukin-6 in sepsis. Blood 74:1704-1710.
12. Heremans, H., C. Dillen, W. Put, J. Van Damme, and A. Billiau. 1992 Protective effect of anti-interleukin (IL)-6 antibody against endotoxin, associated with paradoxically increased IL-6 levels. Eur. J. Immunol. 22:2395-2401.
13. Hubert, D. M., M. Kopf, B. A. Mock, G. Kohler, and S. Rudikoff. 1995. Interleukin-6 is essential for in-vivo development of b-lineage neoplasms. J. Exp. Med. 182:243-248.
14. Kishimoto, T. 1992. Interleukin-6 and its receptor; from cloning to clinic. Int. Arch. Allergy Immunol. 99:172-177.
15. Kopf, M., H. Baumann, G. Freer, M. Freudenberg, M. Lamers, T. Kishimoto, R. Zinkernagel, H. Bluethmann, and G. Kohler. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature (London) 368:339-342.
16. May, L. T., R. Neta, L. L. Moldawer, J. S. Kenney, K. Patel, and P. B. Sehgal. 1993. Antibodies chaperone circulating IL-6. J. Immunol. 151:3225-3236.
17. Poli, V., R. Balena, E. Fattori, A. Markatos, M. Yamamoto, H. Tanaka, G. Ciliberto, G. A. Rodan, and F. Costantini. 1994. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J. 13:1189-96.
18. Rogers, H. W., and E. R. Unanue. 1993. Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice. Infect. Immun. 61:5090-5096.
19. Rothe, G., W. Kellermann, and G. Valet. 1990. Flow cytometric parameters of neutrophil function as early indicators of sepsis- or trauma-related pulmonary or cardiovascular organ failure. J. Lab. Clin. Med. 115:52-61.
20. Sjostedt, A., J. W. Conlan, and R. J. North. 1994. Neutrophils are critical for host defense against primary infection with the facultative intracellular bacterium Francisella tularensis in mice and participate in defense against reinfection. Infect. Immun. 62:2779-83.
21. Starnes, H. F. J., M. K. Pearce, A. Tewari, J. H. Yim, J.-C. Zou, and J. S. Abrams. 1990. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-α challenge in mice. J. Immunol. 145:4185-4191.
22. Suzuki, Y., Q. Yang, F. K. Conley, J. S. Abrams, and J. S. Remington. 1994. Antibody against interleukin-6 reduces inflammation and numbers of cysts in brains of mice with toxoplasmic encephalitis. Infect. Immun. 62:2773-2778.
23. Toft, P., S. T. Lillevang, E. Tonnesen, P. Svendsen, and K. Hohndorf. 1993. Redistribution of lymphocytes following E. coli sepsis. Scand. J. Immunol. 38:541-545.
24. Ulich, T. R., J. del Castillo, and K. Guo. 1989. In vivo hematologic effects of recombinant interleukin 6 on hematopoiesis and circulating numbers of RBCs and WBCs. Blood 73:108-110.
25. van der Poll, T., M. Levi, E. Hack, H. ten Cate, S. J. H. van Deventer, A. J. M. Eerenberg, E. R. de Groot, J. Jansen, H. Gallati, H. R. Buller, J. W. ten Cate, and L. A. Aarden. 1994. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J. Exp. Med. 179:1253-1259.